DL-norvaline attenuated HFD-induced metabolic inflammation and dysfunction with integrated pharmacokinetic, biodistribution, and safety evaluation

Xin Li, Xin Wang, Xin Lü

Open source

DOI
10.1016/j.ejphar.2026.178943
Published
2026-06
Container
European Journal of Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2026.178943,
  title = {DL-norvaline attenuated HFD-induced metabolic inflammation and dysfunction with integrated pharmacokinetic, biodistribution, and safety evaluation},
  author = {Xin Li and Xin Wang and Xin Lü},
  year = {2026},
  journal = {European Journal of Pharmacology},
  doi = {10.1016/j.ejphar.2026.178943},
  url = {https://doi.org/10.1016/j.ejphar.2026.178943}
}

RIS

TY  - JOUR
TI  - DL-norvaline attenuated HFD-induced metabolic inflammation and dysfunction with integrated pharmacokinetic, biodistribution, and safety evaluation
AU  - Xin Li
AU  - Xin Wang
AU  - Xin Lü
PY  - 2026
JO  - European Journal of Pharmacology
DO  - 10.1016/j.ejphar.2026.178943
UR  - https://doi.org/10.1016/j.ejphar.2026.178943
ER  - 

APA

Li, X., Wang, X., & Lü, X. (2026). DL-norvaline attenuated HFD-induced metabolic inflammation and dysfunction with integrated pharmacokinetic, biodistribution, and safety evaluation. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.178943

Source records